Clinical features in Rett syndrome: MECP2-, CDKL5- and FOXGI-related disorders

No To Hattatsu

Volumn 46, Issue 2, 2014, Pages 117-120

  Takahashi, Satoru ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN DEPENDENT KINASE; CYCLIN DEPENDENT KINASE LIKE 5; FORKHEAD BOX GI; FORKHEAD TRANSCRIPTION FACTOR; METHYL CPG BINDING PROTEIN 2; UNCLASSIFIED DRUG;

CLINICAL FEATURE; CONFERENCE PAPER; RETT SYNDROME;

CHILD; CHILD, PRESCHOOL; CHROMOSOMES, HUMAN, X; DNA METHYLATION; FEMALE; FORKHEAD TRANSCRIPTION FACTORS; GENETIC COUNSELING; HUMANS; INFANT; MALE; METHYL-CPG-BINDING PROTEIN 2; MUTATION; NERVE TISSUE PROTEINS; PROTEIN-SERINE-THREONINE KINASES; RETT SYNDROME; TRANSCRIPTION, GENETIC;

EID: 84896533363     PISSN: 00290831     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (20)

1. Amir RE, Van den Veyver IB, Wan M, Tran CQ, Francke U, Zoghbi HY. Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2. Nat Genet 1999; 23: 185-8.
2. Neul JL, Kaufmann WE, Glaze D.G., et al. Rett syndrome: revised diagnostic criteria and nomenclature. Ann Neurol 2010; 68: 944-50.
3. Neul JL, Fang P, Banish J., et al. Specific mutations in methyl-CpG-binding protein 2 confer different severity in Rett syndrome. Neurology 2008; 70: 1313-21.
4. Tao J, Van Esch H, Hagedorn-Greiwe M, et al. Mutations in the X-linked cyclin-dependent kinase-like 5 (CDKL5/STK9) gene are associated with severe neurodevelopmental retardation. Am J Hum Genet 2004; 75: 1149-54.
5. Ariani F, Hayek G, Rondinella D., et al. FOXGl is responsible for the congenital variant of Rett syndrome. Am J Hum Genet 2008; 83: 89-93.
6. Burford B. Perturbations in the development of infants with Rett disorder and the implications for early diagnosis. Brain Dev 2005; 27:S3-7.
7. Einspieler C, Kerr AM, Prechtl HF. Is the early development of girls with Rett disorder really normal? Pediatr Res 2005; 57: 696-700.
8. Steffenburg U, Hagberg G, Hagberg B. Epilepsy in a representative series of Rett syndrome. Acta Paediatr 2001; 90: 34-9.
9. Guerrini R, Parrini E. Epilepsy in Rett syndrome, and CDKL5-and FOXGI-gene-related encephalopathies. Epilepsia 2012; 53: 2067-78.
10. Oexle K, Thamm-Mücke B, Mayer T, Tinschert S. Macrocephalic mental retardation associated with a novel C-terminal MECP2 frameshift deletion. Eur J Pediatr 2005; 164: 154-7.
11. Bahi-Buisson N., Kaminska A, Boddaert N., et al. The three stages of epilepsy in patients with CDKL5 mutations. Epilepsia 2008; 49: 1027-37.
12. Liang JS, Shimojima K, Takayama R., et al. CDKL5 alterations lead to early epileptic encephalopathy in both genders. Epilepsia 2011; 52: 1835-42.
13. Florian C, Bahi-Buisson N, Bienvenu T. FOXGl-Related Disorders: From Clinical Description to Molecular Genetics. Mol Syndromol 2011; 2: 153-63.
14. Takahashi S, Matsumoto N, Okayama A., et al. FOXGl mutations in Japanese patients with the congenital variant of Rett syndrome. Clin Genet 2012; 82: 569-73.
15. Guy J, Gan J, Selfridge J., Cobb S, Bird A. Reversal of neurological defects in a mouse model of Rett syndrome. Science 2007; 315: 1143-7.
16. Baker SA, Chen L, Wilkins A.D., Yu P., Lichtarge O, Zoghbi H Y. An AT-Hook domain in MeCP2 determines the clinical course of Rett Syndrome and related disorders. Cell 2013; 152: 984-96.
17. Villard L. MECP2 mutations in males. J Med Genet 2007; 44: 417-23.
18. Wang IT, Allen M, Goffin D., et al. Loss of CDKL5 disrupts kinome profile and event-related potentials leading to autistic-like phenotypes in mice. Proc Natl Acad Sci USA 2012; 109: 21516-21.
19. Bahi-Buisson N., Villeneuve N, Caietta E., et al. Recurrent mutations in the CDKL5 gene: genotype-phenotype relationships. Am J MedGenetA 2012; 158A: 1612-9.
20. Weaving LS, Christodoulou J, Williamson S.L., et al. Mutations of CDKL5 cause a severe neurodevelopmental disorder with infantile spasms and mental retardation. Am J Hum Genet 2004; 75: 1079-93.